Blueprint to Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices
Oct. 2023: How Egregious Orange Book Manipulation Extended an Insulin Monopoly
Patently unfair: Can waivers help solve COVID vaccine inequality?
The Path to Racial Justice Runs Through This Agency
The Folly of Hoarding Knowledge in the COVID-19 Age
After a pharma lobbying blitz, Congress softens legislation on drug patents
The Health 202: The Supreme Court banned patenting genes. But Congress might change that.
Bringing the medicine access fight to the US
Report Finds 89% of Total U.S. Patent Applications on Humira Were Filed After FDA Approval – Pointing to a Deliberate Strategy to Delay Competition
Femtastic Podcast: How Patent Law Affects Your Health